Streetbeat News

SXTP

60 Degrees Pharmaceuticals, Inc.

Industry

Biotechnology

60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.

Open

1.07

Mkt cap

1.8M

Volume

93K

High

1.08

P/E Ratio

-0.62

52-wk high

18.36

Low

0.94

Div yield

N/A

52-wk low

0.70

On Tuesday, 56 companies hit new 52-week lows. The largest company by market cap to set a new low was Apellis Pharmaceuticals, while the smallest was 9 Meters Biopharma. Humanigen's stock came under the most pressure, trading down 73.22%. NeuBase Therapeutics saw the biggest bounce back, with shares trading up 0.0% after hitting its new 52-week low.

Portfolio Pulse from Benzinga Insights

July 25, 2023 | 4:33 pm

On Monday, 70 companies hit new 52-week lows. Estee Lauder Cos was the largest firm by market cap to set a new 52-week low, while 9 Meters Biopharma was the smallest. AppHarvest was the biggest loser, trading down 70.3% to reach its 52-week low, while SWK Holdings was the biggest winner, with shares trading up 0.0% after rebounding from its new 52-week low.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 7:48 pm

The article lists the stocks that gained and lost in Thursday's mid-day session. Some of the gainers include PainReform Ltd., T2 Biosystems, Inc., SigmaTron International, Inc., and Pasithea Therapeutics Corp. Some of the losers include Vir Biotechnology, Inc., Netcapital Inc., Aspira Women's Health Inc., and DURECT Corporation. Infosys Limited shares declined by 9.4% due to worse-than-expected quarterly earnings results.

Portfolio Pulse from Lisa Levin

July 20, 2023 | 5:26 pm

The article lists the stocks that have gained and lost the most in Wednesday's mid-day session. Among the gainers, Biodexa Pharmaceuticals, SMX, Carvana, and Panbela Therapeutics saw significant increases due to various reasons such as patent allowances, better-than-expected sales, and asset divestitures. Among the losers, Sono Group, Amarin Corporation, Aqua Metals, and Aptevo Therapeutics saw significant decreases due to reasons such as delisting notices, organizational restructuring, and public offerings.

Portfolio Pulse from Lisa Levin

July 19, 2023 | 5:34 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Gainers included enVVeno Medical (NVNO), 60 Degrees (SXTP), Harrow Health (HROW), Panbela Therapeutics (PBLA), DermTech (DMTK), and bluebird bio (BLUE). Losers included Amarin Corp (AMRN), Aptevo Therapeutics (APVO), ViewRay (VRAY), Genprex (GNPX), 9 Meters Biopharma (NMTR), and Context Therapeutics (CNTX).

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 5:31 pm

During Wednesday's pre-market session, several healthcare stocks experienced significant movements. Gainers included 60 Degrees (SXTP), Panbela Therapeutics (PBLA), Bio-Path Hldgs (BPTH), bluebird bio (BLUE), Zynerba Pharmaceuticals (ZYNE), and Prenetics Global (PRE). Losers included Amarin Corp (AMRN), ZyVersa Therapeutics (ZVSA), Dynatronics (DYNT), Biophytis (BPTS), First Wave BioPharma (FWBI), and Milestone Pharmaceuticals (MIST).

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 1:06 pm

Several stocks experienced significant pre-market movements. Notably, bluebird bio, Inc. (NASDAQ:BLUE) shares gained 14% after B of A Securities upgraded the stock from Neutral to Buy and raised the price target from $6 to $10. On the other hand, Sono Group N.V. (NASDAQ:SEV) fell 31.8% after receiving a notice of delisting from the Nasdaq. Other notable movers include 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP), Deep Medicine Acquisition Corp. (NASDAQ:DMAQ), and Startek, Inc. (NYSE:SRT).

Portfolio Pulse from Lisa Levin

July 19, 2023 | 12:12 pm

During Tuesday's trading, 46 companies set new 52-week lows. The largest company by market cap to set a new 52-week low was TELUS (NYSE:TU). American Rebel Holdings (NASDAQ:AREB) was the smallest firm on a market cap basis to set a new 52-week low. 9 Meters Biopharma (NASDAQ:NMTR) was the biggest loser, trading down 68.25% to reach its 52-week low. Shuttle Pharmaceuticals (NASDAQ:SHPH) saw the sharpest rebound, as shares ascended 0.0%, reversing after hitting a new 52-week low.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 5:47 pm

Several stocks experienced significant movement in Monday's mid-day session. ProMIS Neurosciences, Acumen Pharmaceuticals, BridgeBio Pharma, Lixte Biotechnology Holdings, and Healthcare Triangle were among the top gainers, with shares jumping due to various reasons such as positive preclinical data, successful Phase 1 studies, and strong financial results. On the other hand, Novan, ViewRay, UTime Limited, Jiuzi Holdings, and BYND Cannasoft Enterprises were among the biggest losers, with shares falling due to factors such as asset sales, Chapter 11 filings, and direct offerings.

Portfolio Pulse from Lisa Levin

July 17, 2023 | 5:14 pm

On Monday, 50 companies reached new 52-week lows. The biggest company by market cap to set a new 52-week low was Verizon Communications (NYSE:VZ), while the smallest was Galmed Pharmaceuticals (NASDAQ:GLMD). Novan (NASDAQ:NOVN) was the biggest loser of the morning session, dropping 72.16% to reach its new 52-week low. Cal-Maine Foods (NASDAQ:CALM) shares were the most resilient, rising 0.06% from its new 52-week low.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 4:17 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.